Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07185737 · ClinicalTrials.gov registry record · NA

Culturally Adapted RUBI-T for Spanish-Speaking Families in Texas and Mexico

A NA study, sponsored by Baylor University.

Not yet
Registry status
NA
Development phase
120
Enrollment target

NCT07185737: Clinical Trial NA study, sponsored by Baylor University.

NCT07185737 is a NA study that has not yet begun recruiting, run by Baylor University. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07185737, a NA study, has not yet begun recruiting, sponsored by Baylor University.

NOT YET RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

Supporting young autistic children can sometimes be very stressful, especially when children show behaviors that are difficult to understand and/or manage in everyday life. Research has shown that teaching parents practical strategies through programs like the Research Units in Behavioral Intervention (RUBI) can reduce these behaviors and help parents feel more confident. However, most of these programs have only been studied with English-speaking families, which means Spanish-speaking caregivers often do not have access to support that feels relevant to their culture and language. This study will test a version of RUBI that has been adapted for Spanish-speaking families in the U.S. and Mexico. We will invite 100 parents of autistic children between the ages of 2 and 9 to take part. Half will start the program right away, while the other half will wait and receive it later. Parents in the program will join eight online group sessions, use a Spanish handbook at home, and practice strategies with support from trained facilitators. We will look at whether the program helps reduce children's challenging behaviors, lowers parent stress, and increases parents' confidence in managing behaviors. We will also ask parents to share their experiences and opinions about how well the program fits their culture and daily life. By combining numbers (surveys) and stories (interviews), this project will show whether the adapted program works well for Spanish-speaking families. The results can help make autism services more fair, accessible, and supportive for families from diverse backgrounds.

Primary Outcome

The HSQ-ASD (Chowdhury et al., 2016) is a 24-item caregiver-report tool assessing severity of challenging behaviors in children with autism across daily situations. Higher scores indicate more severe problem behaviors.

Interventions

  • BEHAVIORAL Adapted RUBI-Telehealth

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-09-25
Est. Completion 2026-12-31
Phase NA
Baylor University

33 total trials

What is known before NCT07185737 opens enrollment

NCT07185737 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Adapted RUBI-Telehealth is the first listed.

NCT07185737 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07185737 about?

NCT07185737 is a clinical study titled "Culturally Adapted RUBI-T for Spanish-Speaking Families in Texas and Mexico". Supporting young autistic children can sometimes be very stressful, especially when children show behaviors that are difficult to understand and/or manage in everyday life. Research has shown that teaching parents practical strategies through programs like the Research Units in Behavioral Interventi...

What is the current status of trial NCT07185737?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-09-25. Estimated completion is 2026-12-31.

What interventions are being tested in trial NCT07185737?

The interventions under investigation include: Adapted RUBI-Telehealth (BEHAVIORAL).

Who is sponsoring clinical trial NCT07185737?

This trial is sponsored by Baylor University, which has 33 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07185737's enrollment target sits among peer trials

120 762nd of 2000 higher than 1,198 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07185737, the US trial registry maintained by the National Library of Medicine. NCT07185737 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.